๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis
NCT07352358Cerebral Venous Thrombosis
Xuanwu Hospital, Beijing
Phase 4
72
Beijing
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Beijing, Wuhan, Nanjing, Shanghai, Taizhou
2026-01-30
Recruiting
A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors
NCT07328217Advanced Solid Tumors
Dizal Pharmaceuticals
Phase 1/2
203
Beijing
2026-01-29
Recruiting
Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC
NCT07492342Resectable NSCLC, KRAS G12C Mutation, Stage IB-IIIA NSCLC, Neoadjuvant Therapy
Jianxing He
Phase 2
30
Beijing, Guangzhou, Zhejiang
2026-01-29
Recruiting
A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)
NCT07208149Triple-Negative Breast Cancer (TNBC)
Shenzhen Majory Biotechnology Co., Ltd.
Phase 1/2
42
Beijing
2026-01-29
Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
NCT07227597Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC
Phase 1/2
170
Beijing, Fuzhou, Guangzhou, Jiangmen, Nanchang, Shanghai, Chengdu, Hangzhou
2026-01-29
Recruiting
Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain
NCT07318688Endometriosis
Hope Medicine (Nanjing) Co., Ltd
Phase 3
540
Beijing, Nanning, Suzhu, Shanghai, Tianjin
2026-01-29
Recruiting
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
NCT07363642Severe Asthma
AstraZeneca
Phase 3
400
Beijing, Binzhou, Changsha, Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou
2026-01-28
Recruiting
Effect of Intrauterine Insemination on Subsequent Pregnancy Outcomes in Couples With Unexplained Pregnancy Loss: A Multicenter, Open-label, Randomized Controlled Trial
NCT07759609Unexplained Pregnancy Loss
Lanzhou University Second Hospital
Not applicable
558
Beijing, Lanzhou, Shijiazhuang
2026-01-27
Not yet open
Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients
NCT07380230Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer
LI FENG
Not applicable
60
Beijing
2026-01-27
Not yet open
Preventing Neurologic Complications in Valve Surgery
NCT07382362Left Atrial Appendage Closure
China National Center for Cardiovascular Diseases
Observational
100
Beijing, Qingdao, Shenzhen
2026-01-27
Recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263Hidradenitis Suppurativa
Takeda
Phase 2
90
Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou
2026-01-26
Recruiting
Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
NCT07304518Migraine
Sichuan Purity Pharmaceutical Technology Co., Ltd.
Phase 2
456
Beijing
2026-01-26
Recruiting
Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants
NCT07419698Healthy Participants
Shanghai JMT-Bio Inc.
Phase 1
44
Beijing
2026-01-26
Active, closed
Time-Restricted Eating for Weight-Loss Maintenance
NCT07163455Overweight or Obese Adults
Harbin Medical University
Not applicable
500
Beijing, Chongqing, Shenzhen, Harbin, Xi'an, Qingdao, Weifang, Chengdu
2026-01-26
Recruiting
Rehabilitation Exercise Against Complications in High-risk Elderly After Lumbar Fusion(REACH)
NCT07396051Adjacent Segment Degeneration, Multimodal Rehabilitation, Lumber Fusion
Xuanwu Hospital, Beijing
Not applicable
212
Beijing
2026-01-25
Not yet open
The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke
NCT07269288Acute Ischemic Stroke
Peking University Aerospace Center Hospital
Observational
1,500
Beijing
2026-01-25
Recruiting
Research and Clinical Validation of a Wearable Device-Based Remote Rehabilitation System for Postoperative Rotator Cuff Injury
NCT07412184Rotator Cuff Tear
Peking University Third Hospital
Not applicable
72
Beijing
2026-01-23
By invitation
Vaginal Function Exercisers and Vaginal Dilation Irrigation Drug Administration Tubes Are Used for Vaginal Rehabilitation Therapy in Pelvic Radiotherapy
NCT07473271Indicated for Pelvic Radiotherapy, Vaginal Rehabilitation, and Alleviation of Late Toxic Reactions in the Vagina
Peking Union Medical College Hospital
Not applicable
76
Beijing
2026-01-23
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
NCT07277231Chronic Lymphocytic Leukemia
BeOne Medicines
Phase 3
500
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Harbin, Zhengzhou
2026-01-22
Recruiting
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT07357987Ischemic Stroke, Medium Vessel Occlusion, Tenecteplase, Endovascular Treatment
Beijing Tiantan Hospital
Phase 3
488
Beijing
2026-01-22
Recruiting
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
NCT07269145Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
86
Beijing, Fuzhou, Meizhou, Shanghai, Chengdu
2026-01-22
Recruiting
Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
NCT07292441Overweight or Obesity
Gan & Lee Pharmaceuticals.
Phase 3
500
Beijing
2026-01-22
Recruiting
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT07347600Locally Advanced Breast Cancer, Metastatic Breast Cancer
Hoffmann-La Roche
Observational
500
Xiamen, Lanzhou, Changchun, Wenzhou, Beijing, Chengdu, Chongqing, Guangzhou
2026-01-21
Recruiting
Application of a Wearable Device-Based Intelligent Rehabilitation System in the Rehabilitation of Patients With Frozen Shoulder
NCT07422714Range of Motion, Articular
Peking University Third Hospital
Not applicable
42
Beijing
2026-01-21
Recruiting
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
NCT07309562Small for Gestational Age
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
141
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou
2026-01-20
Active, closed
Multimodal Neurofunctional Profiling in Stroke
NCT07411573Stroke
Peking Union Medical College Hospital
Observational
1,000
Beijing
2026-01-20
Recruiting
A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment
NCT07413042SCLC, Extensive Stage
Peking University Cancer Hospital & Institute
Phase 1
24
Beijing
2026-01-20
Recruiting
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
NCT07203625Acute Ischemic Stroke, Basilar Artery Occlusion
Xuanwu Hospital, Beijing
Phase 4
316
Beijing
2026-01-20
Recruiting
A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
NCT07339267Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc.
Phase 1
12
Beijing
2026-01-20
Active, closed
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
NCT07230860Dermatitis, Atopic
Janssen Research & Development, LLC
Phase 2
189
Beijing, Changsha, Chengde, Chengdu, Guangzhou, Sanmenxia, Wuxi, Xi'an
2026-01-20
Not yet open
A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT07313917Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Longbio Pharma
Phase 2
150
Beijing
2026-01-20
Recruiting
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
NCT07263594Gastrointestinal Cancer
DualityBio Inc.
Phase 1/2
127
Beijing
2026-01-20
Active, closed
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
NCT07233655Moderate to Severe Active Rheumatoid Arthritis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
30
Beijing
2026-01-19
Recruiting
Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study
NCT07556224Ankylosing Spondylitis (AS)
China-Japan Friendship Hospital
Observational
790
Beijing
2026-01-19
Recruiting
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
NCT07509775Ankylosing Spondylitis (AS)
China-Japan Friendship Hospital
Observational
210
Beijing
2026-01-19
Not yet open
Safety and Efficacy of a Novel Composite-Tip Guiding Catheter in Transcarotid Artery Stenting Via Transradial Access
NCT07377422Transradial Carotid Artery Stenting, Novel Composite-tip Guiding Catheter
Beijing Anzhen Hospital
Not applicable
204
Beijing
2026-01-19
Recruiting
Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
NCT06526598Critical Care, Acute Hypoxic Respiratory Failure, Ventilator-Induced Lung Injury
Capital Medical University
Not applicable
619
Beijing
2026-01-19
Not yet open
Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery
NCT07367542Depression, Anxiety, S-ketamine, Breast Cancer
Chinese PLA General Hospital
Not applicable
218
Beijing
2026-01-17
Recruiting
Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRC
NCT07724223Metastatic Colorectal Cancer (CRC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
46
Beijing
2026-01-16
Active, closed
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
NCT07230119Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 3
755
Xuancheng, Beijing, Chongqing, Lanzhou, Guangzhou, Huizhou, Nanning, Handan
2026-01-16
Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
NCT07195695Non-small Cell Lung Cancer
Boehringer Ingelheim
Phase 3
400
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan
2026-01-16
Not yet open
A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia
NCT07357012Benign Prostatic Hyperplasia
Peking University Third Hospital
Observational
40
Beijing
2026-01-15
Not yet open
Effect of Intranasal Negative Pressure Therapy on Cognitive Function in Patients With Mild Cognitive Impairment and Obstructive Sleep Apnea
NCT07353359Mild Cognitive Impairment (MCI)
Xuanwu Hospital, Beijing
Not applicable
65
Beijing
2026-01-15
Not yet open
Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia
NCT07321535Sarcopenia
Wangjing Hospital, China Academy of Chinese Medical Sciences
Not applicable
106
Beijing, Changsha, Tianjin
2026-01-15
Recruiting
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets
NCT07647783Healthy Participants
InnovStone Therapeutics Limited
Phase 1
112
Beijing
2026-01-15
Recruiting
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
NCT07321873Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 2
240
Beijing, Changsha, Changzhou, Chengdu, Chongqing, Hangzhou, Ningbo, Shanghai
2026-01-15
Recruiting
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
NCT07297212Recurrent Glioblastoma
BioNTech SE
Phase 2
75
Beijing, Chongqing, Jinan, Shanghai, Shenzhen, Wuhan
2026-01-15
Recruiting
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
NCT07361289Hypertrophic Cardiomyopathy
Bristol-Myers Squibb
Observational
500
Beijing, Guangzhou, Jiazhuang, Harbin, Zhengzhou, Suzhou, Changchun, Dalian
2026-01-15
Not yet open
Effects of a Specific Dietary Program on Overweight/Obese Women With Polycystic Ovary Syndrome: A Multicenter, Prospective, Randomized Controlled Clinical Study
NCT07350889Polycystic Ovary Syndrome (PCOS)
Xuanwu Hospital, Beijing
Not applicable
160
Beijing
2026-01-15
Active, closed
A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
NCT07266090SLE - Systemic Lupus Erythematosus
Viatris Pharmaceuticals Co., Ltd.
Phase 2
15
Guangzhou, Shijiazhuang, Luoyang, Zhengzhou, Jiujiang, Nanchang, Beijing
2026-01-14
Recruiting
Prediction Model for MINS After Major Hepatobiliary Surgery
NCT07335042Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm, Hepatobiliary Diseases
Beijing Tsinghua Chang Gung Hospital
Observational
1,800
Beijing, Chongqing, Qingdao, Shandong, Zhuhai
2026-01-14
Recruiting
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
NCT07317934Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Innostellar Biotherapeutics Co.,Ltd
Phase 3
388
Hefei, Beijing, Chongqing, Guangzhou, Shantou, Zhongshan, Xingtai, Harbin
2026-01-14
Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
NCT07325292Multiple Sclerosis
Sanofi
Phase 3
160
Beijing, Chengdu, Jiazhuang
2026-01-14
Active, closed
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
NCT07297797Mild to Moderate Hypertension
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
238
Beijing
2026-01-14
Recruiting
A Phase I Study of JLM019 Injection
NCT07623850Advanced Solid Tumor (Phase 1), Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Jecho Biopharmaceuticals Co., Ltd.
Phase 1
115
Beijing
2026-01-13
Recruiting
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
NCT07249632Myasthenia Gravis, Ocular
RemeGen Co., Ltd.
Phase 3
120
Beijing
2026-01-13
By invitation
Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT
NCT07690306Prostate Cancer (Diagnosis)
Xiangya Hospital of Central South University
Observational
1,500
Beijing, Guangzhou, Jinan, Shanghai
2026-01-13
Recruiting
A Phase I Trial of A-CAR032 in Participants With mCRPC
NCT07344311Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Shanghai AbelZeta Ltd.
Phase 1
27
Beijing, Wuhan, Xuzhou, Hangzhou
2026-01-13
Not yet open
Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion
NCT07335107Acute Ischemic Stroke
Beijing Tiantan Hospital
Phase 3
564
Beijing
2026-01-12
Recruiting
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
NCT07279428Gastrointestinal Tumors, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
33
Beijing
2026-01-12
Recruiting
Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery
NCT07332806Robotic Surgical Procedures, Airway Extubation, Operating Rooms, Anesthesia Recovery Period
Peking University First Hospital
Not applicable
218
Beijing
2026-01-12
Recruiting
Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
NCT07349160Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
36
Beijing
2026-01-10
Not yet open
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma๏ผˆLB2505-0001๏ผ‰
NCT07399444Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
38
Zhengzhou, Wuhan, Xuzhou, Nanchang, Beijing, Tianjin
2026-01-10
Recruiting
Fucoidan in the Treatment of Active Rheumatoid Arthritis
NCT07045896Arthritis, Rheumatoid
Peking University People's Hospital
Not applicable
40
Beijing
2026-01-10
Not yet open
Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents
NCT07339956Gastrointestinal Bleeding
China-Japan Friendship Hospital
Phase EARLY_PHASE1
60
Beijing
2026-01-10
Active, closed
Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia
NCT07733037Immune Thrombocytopenia (ITP)
Peking University People's Hospital
Phase 2
42
Beijing
2026-01-10
Not yet open
Osteoporotic Vertebral Compression Fracture Cohort Study
NCT07321795OVCF Database, Cohort Study
Wangjing Hospital, China Academy of Chinese Medical Sciences
Observational
200
Hunan, Suzhou, Weihai, Beijing
2026-01-10
Recruiting
Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis
NCT07242768Ischemic Stroke, Transient Ischemic Attack
Capital Medical University
Observational
1,300
Beijing
2026-01-10
Active, closed
LishitonglinUS-01 Trial
NCT07769060Urethra Stricture
Peking University First Hospital
Phase 2
120
Beijing
2026-01-09
Recruiting
An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors
NCT07359066Advanced Solid Tumors, PARP Inhibitor
Shanghai SciBrunch Therapeutics Co., Ltd.
Phase 1/2
210
Beijing, Harbin
2026-01-08
Recruiting
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
NCT07388602Amyloidosis
Sinocelltech Ltd.
Phase 3
90
Beijing
2026-01-08
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285Overweight, Obesity
Novo Nordisk A/S
Phase 3
460
Beijing, Zhengzhou, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2026-01-08
Recruiting
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
NCT07296341Locally Advanced or Metastatic Pancreatic Cancer With
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
60
Beijing
2026-01-08
Recruiting
Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia
NCT07311343Hemorrhage, Pneumonia
Beijing Tiantan Hospital
Phase 4
440
Beijing
2026-01-07
Recruiting
Photon-Counting Cardiac CT in Post-PCI Patients
NCT07763340Cardiovascular Diseases
Chinese PLA General Hospital
Observational
800
Beijing
2026-01-07
Recruiting
An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma
NCT07344818R/R Aggressive B-cell Lymphoma
Peking University People's Hospital
Phase EARLY_PHASE1
18
Beijing
2026-01-07
Recruiting
Photon-counting CT for Intracranial Stent Assessment
NCT07769814Intracranial Atherosclerotic Disease (ICAD), Intracranial Arterial Stenosis, Stent Restenosis, Ischemic Stroke
Xin Lou
Observational
200
Beijing
2026-01-07
Recruiting
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patients With Carotid Artery Stenosis
NCT07762664Carotid Artery Stenosis, Carotid Atherosclerosis, Carotid Atherosclerotic Plaque
Chinese PLA General Hospital
Observational
100
Beijing
2026-01-07
Recruiting
This Prospective Observational Study Aims to Evaluate the Capability of Ultra-high-resolution Photon-counting CT Angiography (UHR PCD-CTA) for Noninvasive Evaluation of Intracranial Venous Sinus Stents. The Study Will Compare Image Quality, Stent Visualization, Metal-related Artifacts, and Diagnosti
NCT07762677Intracranial Stenosis, Venous Sinus Stenosis, Stent Implantation, Intracranial Venous Pressures
Xin Lou
Observational
200
Beijing
2026-01-07
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Huizhou, Jiangmen, Nanning
2026-01-06
Recruiting
Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
NCT07239596Advanced Renal Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
92
Beijing
2026-01-06
Recruiting
Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
NCT07253181Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients
Xuanwu Hospital, Beijing
Phase 3
572
Beijing, Weifang
2026-01-06
Recruiting
A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China
NCT07821957Intracranial Aneurysm
Beijing Tiantan Hospital
Not applicable
280
Beijing
2026-01-06
Recruiting
Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery
NCT07308756General Anesthesia, Surgery, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
316
Beijing
2026-01-05
Recruiting
A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
NCT07289477Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
iRegene Therapeutics Co., Ltd.
Phase 1
9
Beijing
2026-01-05
Recruiting
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
NCT07318818Recurrent Glioblastoma IDH Wildtype
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2
26
Beijing
2026-01-05
Recruiting
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
NCT07435701Ovarian Neoplasms Malignant, Ascites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
29
Beijing
2026-01-05
Recruiting
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
NCT07354711Lung Cancer, Stomach Cancer
3H Pharmaceuticals Co., Ltd.
Phase 1/2
170
Beijing
2026-01-04
Recruiting
An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC
NCT07452003Non-Small Cell Lung Cancer
Peking Union Medical College Hospital
Not applicable
30
Beijing
2026-01-03
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT07063745Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Bristol-Myers Squibb
Phase 2/3
590
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Nanning
2026-01-02
Recruiting
Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism
NCT07724197Pulmonary Embolism Acute
Beijing Tsinghua Chang Gung Hospital
Observational
275
Beijing, Chenzhou, Loudi
2026-01-02
Active, closed
Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer
NCT07429318Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing
2026-01-01
Not yet open
ICSI Versus Conventional IVF in Couples With Unexplained Infertility
NCT07294027Unexplained Infertility
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
848
Beijing, Huangshi, Wuhan, Xiangyang, Hangzhou, Jiaxing, Ningbo
2026-01-01
Not yet open
A Prospective Multicenter Clinical Study on the Efficacy and Safety of the Zirconia Ceramic Hip Joint Prosthesis System After Its Market Launch
NCT07382050THA, Prosthesis
Peking University Third Hospital
Observational
290
Beijing
2026-01-01
Recruiting
Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC
NCT07618078Nasopharyngeal Carcinoma (NPC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
900
Beijing
2026-01-01
Not yet open
Risk of Acute Kidney Injury in Pulmonary Endarterectomy
NCT07135206Acute Kidney Injury
China-Japan Friendship Hospital
Observational
284
Beijing
2026-01-01
Not yet open
A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)
NCT07365371Polypoidal Choroidal Vasculopathy (PCV), Neovascular Age Related Macular Degeneration (AMD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
174
Beijing, Foshan, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Jilin City
2026-01-01
Not yet open
Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness
NCT07274683Stellate Ganglion Block, Prolonged Disorders of Consciousness, Sleep
Beijing Tiantan Hospital
Observational
25
Beijing
2026-01-01
Recruiting
SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
NCT07614230Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease, Atherosclerosis
Junjie Yang
Phase 4
144
Beijing
2026-01-01
Rows per page Showing 1101–1200 of 5484
Previous 10 11 12 13 14 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=12

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.